retatrutide ישראל התרופה החדשה שמבטיחה ירידה של 30% במשקל – אך מעוררת חשש בקרב הרופאים ADA26: retatrutide delivers unprecedented weight

BACKGROUND Heart failure with a preserved ejection fraction (HFpEF) is characterized by frequent hospitalizations, and substantial mortality

Aljabali, Yahia El-Tanani, Dimitrios Patoulias, Manfredi Rizzo Current Pharmaceutical Design .2026

Oral formulations also exist, giving patients who dislike injections an alternative route

GLP-1 actions beyond insulin secretion and body weight Clinically, GLP-1RAs are used to treat people with T2D and/or obesity (Figure 1), based on mechanisms described above linked to control of insulin and glucagon secretion, as well as reduction of food intake

By now Im sure youve heard the stories of incredible weight loss experienced by celebrities or maybe even someone you know by using these drugs

How Retatrutide Compares to Other GLP-1 Medications Retatrutide differs from earlier GLP-1 medications in its mechanism